Closed tender

NHS National Framework for Natalizumab-February 2024

Details

Value
£175,000,000
Topic
Pharmaceutical products
Published
2 November 2023
Submission
4 December 2023

Tender description

NHS National Framework for Natalizumab - February 2024<br/>Offer reference number: CM/PHR/23/5701<br/>Period of framework: 1 February 2024 to 31 August 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months Lot 1: NHS National Framework for Natalizumab - February 2024<br/>Offer reference number: CM/PHR/23/5701<br/>Period of framework: 1 February 2024 to 31 August 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Lot 1: NHS National Framework for Natalizumab - February 2024<br/>Offer reference number: CM/PHR/23/5701<br/>Period of framework: 1 February 2024 to 31 August 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.

Timeline

  1. Completed: Tender published2 November 2023
    Current notice
  2. Completed: Submission date4 December 2023

About the buyer

NHS England is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.

Relevant CPV codes

  • 33600000 · Pharmaceutical products

AI insights

  • Is there a preferred supplier?
  • What are the buyers pain points?
  • What has the buyer previously procured?
  • What are the key requirements?
Sign-up to enrich

Decision makers

Connect with the people behind this procurement.

Contact nameJob titlePhone numberWork email
Head of Procurement+44 •••• ••••••
Commercial Director+44 •••• ••••••
Procurement Manager+44 •••• ••••••
Category Lead+44 •••• ••••••
Senior Buyer+44 •••• ••••••
Contracts Manager+44 •••• ••••••

Win more public sector contracts

Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.